- Home
- SAMG vs ALEC Comparison
SAMG vs ALEC Comparison
Compare SAMG & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAMG
- ALEC
- Stock Information
- Founded
- SAMG 2002
- ALEC 2013
- Country
- SAMG United States
- ALEC United States
- Employees
- SAMG N/A
- ALEC N/A
- Industry
- SAMG Investment Managers
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SAMG Finance
- ALEC Health Care
- Exchange
- SAMG Nasdaq
- ALEC Nasdaq
- Market Cap
- SAMG 151.4M
- ALEC 124.0M
- IPO Year
- SAMG 2013
- ALEC 2019
- Fundamental
- Price
- SAMG $16.52
- ALEC $1.51
- Analyst Decision
- SAMG
- ALEC Buy
- Analyst Count
- SAMG 0
- ALEC 7
- Target Price
- SAMG N/A
- ALEC $4.70
- AVG Volume (30 Days)
- SAMG 69.5K
- ALEC 561.0K
- Earning Date
- SAMG 07-31-2025
- ALEC 08-06-2025
- Dividend Yield
- SAMG 4.84%
- ALEC N/A
- EPS Growth
- SAMG N/A
- ALEC N/A
- EPS
- SAMG 0.94
- ALEC N/A
- Revenue
- SAMG $124,771,000.00
- ALEC $88,339,000.00
- Revenue This Year
- SAMG $3.93
- ALEC N/A
- Revenue Next Year
- SAMG $5.56
- ALEC $319.82
- P/E Ratio
- SAMG $17.57
- ALEC N/A
- Revenue Growth
- SAMG 5.51
- ALEC N/A
- 52 Week Low
- SAMG $13.54
- ALEC $0.87
- 52 Week High
- SAMG $19.20
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- SAMG 69.26
- ALEC 55.23
- Support Level
- SAMG $15.25
- ALEC $1.34
- Resistance Level
- SAMG $16.61
- ALEC $1.56
- Average True Range (ATR)
- SAMG 0.41
- ALEC 0.12
- MACD
- SAMG 0.17
- ALEC -0.01
- Stochastic Oscillator
- SAMG 99.08
- ALEC 60.93
About SAMG Silvercrest Asset Management Group Inc.
Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.